CVS Pushes Drug Wholesalers To Drop Secondary Market Purchases
This article was originally published in The Pink Sheet Daily
CVS will no longer purchase pharmaceuticals from distributors that participate in the secondary wholesale market. Each of the top three wholesalers purchases about 0.5% of its drugs from sources other than the manufacturer.
You may also be interested in...
Pharmaceutical wholesalers including Cardinal, ABC are subpoenaed by AG Eliot Spitzer's office in an inquiry into the wholesale secondary market, which has been associated with counterfeiting. The three top wholesalers have previously stated their intentions to cut back on secondary purchases.
FDA is clarifying that it expects sponsors to provide analysis of efficacy data rather than simply a summary of clinical data as part of the integrated summary of effectiveness in new drug applications
Interim data from SHARP and IMPROVE-IT trials fail to show evidence of impact on cancer rates.